Chordia Therapeutics (190A.TSE) Q2 2025 Earnings

11AprConfirmed
Q4 2024
Q1 2025
Q2 2025
-10
-9
-7
-5

Details

Expected EPS
N/A
Actual EPS
-5
Surprise EPS
-5
Surprise Percent
+∞%

Description

Chordia Therapeutics (190A.TSE) has reported earnings of -5 per share for Q2 2025.

0 Comments

Share your thoughts